Professor Brendan Murphy Chief Medical Officer endorsing the 25 million dose purchase.

Moderna said it would provide 25 million doses of their mRNA vaccine, with 10 million of those doses, effective against what they labelled the "ancestral strain" of COVID-19, to arrive in 2021.